Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07664956 · ClinicalTrials.gov registry record · Phase 4
Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy
A Phase 4 study, sponsored by Christiana Care Health Services.
- Not yet
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT07664956: Clinical Trial Phase 4 study, sponsored by Christiana Care Health Services.
NCT07664956 is a Phase 4 study that has not yet begun recruiting, run by Christiana Care Health Services. The registered enrollment target is 36 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07664956, a Phase 4 study, has not yet begun recruiting, sponsored by Christiana Care Health Services.
- NOT YET RECRUITING
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
Primary Outcome
The primary objective of the study will be to assess pain scores via Visual Analog Scale (VAS) on Post Op Day 3 compared between the control group vs cyclobenzaprine group. Ratings will be from 0 to 10, which are associated with visual cues to aid in selection. As stated above, VAS pain scores will be collected electronically via REDCap. The survey will be distributed via Doximity text or patient portal message.
Interventions
- DRUG Cyclobenzaprine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-07-01 |
| Est. Completion | 2026-12-01 |
| Phase | Phase 4 |
What is known before NCT07664956 opens enrollment
NCT07664956 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Cyclobenzaprine is the first listed.
NCT07664956 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07664956 about?
NCT07664956 is a clinical study titled "Cyclobenzaprine for Postoperative Pain in Minimally Invasive Hysterectomy". Typical postoperative pain control after minimally invasive hysterectomy includes ibuprofen, acetaminophen, and a short course of narcotics. The purpose of this study is to see if adding cyclobenzaprine to this regime improves pain control and lessens narcotic use.
What is the current status of trial NCT07664956?
This trial is currently not yet recruiting. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2026-07-01. Estimated completion is 2026-12-01.
What interventions are being tested in trial NCT07664956?
The interventions under investigation include: Cyclobenzaprine (DRUG).
Who is sponsoring clinical trial NCT07664956?
This trial is sponsored by Christiana Care Health Services, which has 82 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07664956's enrollment target sits among peer trials
36 1490th of 2000 higher than 495 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI